Sufficiency of Single‐Arm Studies to Support Registration of Targeted Agents in Molecularly Selected Patients with Cancer: Lessons from the Clinical Development of Crizotinib

Detalles Bibliográficos
Autores principales: Selaru, P, Tang, Y, Huang, B, Polli, A, Wilner, KD, Donnelly, E, Cohen, DP
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351315/
https://www.ncbi.nlm.nih.gov/pubmed/26841346
http://dx.doi.org/10.1111/cts.12388
_version_ 1782514754006286336
author Selaru, P
Tang, Y
Huang, B
Polli, A
Wilner, KD
Donnelly, E
Cohen, DP
author_facet Selaru, P
Tang, Y
Huang, B
Polli, A
Wilner, KD
Donnelly, E
Cohen, DP
author_sort Selaru, P
collection PubMed
description
format Online
Article
Text
id pubmed-5351315
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-53513152017-05-23 Sufficiency of Single‐Arm Studies to Support Registration of Targeted Agents in Molecularly Selected Patients with Cancer: Lessons from the Clinical Development of Crizotinib Selaru, P Tang, Y Huang, B Polli, A Wilner, KD Donnelly, E Cohen, DP Clin Transl Sci Research John Wiley and Sons Inc. 2016-03-01 2016-04 /pmc/articles/PMC5351315/ /pubmed/26841346 http://dx.doi.org/10.1111/cts.12388 Text en © 2016 The Authors. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research
Selaru, P
Tang, Y
Huang, B
Polli, A
Wilner, KD
Donnelly, E
Cohen, DP
Sufficiency of Single‐Arm Studies to Support Registration of Targeted Agents in Molecularly Selected Patients with Cancer: Lessons from the Clinical Development of Crizotinib
title Sufficiency of Single‐Arm Studies to Support Registration of Targeted Agents in Molecularly Selected Patients with Cancer: Lessons from the Clinical Development of Crizotinib
title_full Sufficiency of Single‐Arm Studies to Support Registration of Targeted Agents in Molecularly Selected Patients with Cancer: Lessons from the Clinical Development of Crizotinib
title_fullStr Sufficiency of Single‐Arm Studies to Support Registration of Targeted Agents in Molecularly Selected Patients with Cancer: Lessons from the Clinical Development of Crizotinib
title_full_unstemmed Sufficiency of Single‐Arm Studies to Support Registration of Targeted Agents in Molecularly Selected Patients with Cancer: Lessons from the Clinical Development of Crizotinib
title_short Sufficiency of Single‐Arm Studies to Support Registration of Targeted Agents in Molecularly Selected Patients with Cancer: Lessons from the Clinical Development of Crizotinib
title_sort sufficiency of single‐arm studies to support registration of targeted agents in molecularly selected patients with cancer: lessons from the clinical development of crizotinib
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351315/
https://www.ncbi.nlm.nih.gov/pubmed/26841346
http://dx.doi.org/10.1111/cts.12388
work_keys_str_mv AT selarup sufficiencyofsinglearmstudiestosupportregistrationoftargetedagentsinmolecularlyselectedpatientswithcancerlessonsfromtheclinicaldevelopmentofcrizotinib
AT tangy sufficiencyofsinglearmstudiestosupportregistrationoftargetedagentsinmolecularlyselectedpatientswithcancerlessonsfromtheclinicaldevelopmentofcrizotinib
AT huangb sufficiencyofsinglearmstudiestosupportregistrationoftargetedagentsinmolecularlyselectedpatientswithcancerlessonsfromtheclinicaldevelopmentofcrizotinib
AT pollia sufficiencyofsinglearmstudiestosupportregistrationoftargetedagentsinmolecularlyselectedpatientswithcancerlessonsfromtheclinicaldevelopmentofcrizotinib
AT wilnerkd sufficiencyofsinglearmstudiestosupportregistrationoftargetedagentsinmolecularlyselectedpatientswithcancerlessonsfromtheclinicaldevelopmentofcrizotinib
AT donnellye sufficiencyofsinglearmstudiestosupportregistrationoftargetedagentsinmolecularlyselectedpatientswithcancerlessonsfromtheclinicaldevelopmentofcrizotinib
AT cohendp sufficiencyofsinglearmstudiestosupportregistrationoftargetedagentsinmolecularlyselectedpatientswithcancerlessonsfromtheclinicaldevelopmentofcrizotinib

Ejemplares similares